發(fā)布時(shí)間：2018-04-25 06:47

  本文選題：催乳素腺瘤 + 催乳素　； 參考：《廣西醫(yī)科大學(xué)》2017年碩士論文

【摘要】：目的:探討經(jīng)單鼻孔蝶竇入路切除垂體PRL腺瘤的手術(shù)治療效果。方法:回顧性分析35例在我院神經(jīng)外科接受經(jīng)單鼻孔蝶竇入路垂體PRL腺瘤切除手術(shù)患者的臨床資料。檢測(cè)患者術(shù)前及術(shù)后血PRL水平,并對(duì)可能影響手術(shù)療效的因素如腫瘤大小、腫瘤切除程度及侵襲性進(jìn)行統(tǒng)計(jì)學(xué)分析。結(jié)果:男性發(fā)病率要低于女性,男女比率為1:1.19;占位效應(yīng)引起的最常見的臨床表現(xiàn)為頭痛(34.29%)、視覺障礙(40%);內(nèi)分泌異常導(dǎo)致男性患者主要表現(xiàn)為性功能下降(18.75%),女性主要表現(xiàn)為閉經(jīng)(73.68%)、泌乳(21.05%)、不孕(26.32%);男女患者術(shù)前PRL水平存在差異(P=0.047);男性患者與女性患者腫瘤大小存在差異(P=0.009);術(shù)前PRL水平影響術(shù)后第1天PRL水平(P=0.033);手術(shù)腫瘤全切患者比未全切患者治愈率高(P=0.006);腫瘤大小影響手術(shù)治療效果(P=0.004);術(shù)后第1天的血PRL20ng/ml與PRL20ng/ml,患者復(fù)發(fā)率存在差異(P=0.031);侵襲性與非侵襲性PRL腺瘤患者的術(shù)后復(fù)發(fā)率比較差異有統(tǒng)計(jì)學(xué)意義(P=0.004)。結(jié)論:男性患者就診時(shí)PRL水平更高腫瘤更大;術(shù)前PRL200ng/ml患者術(shù)后治愈率比術(shù)前PRL200ng/ml患者要低;手術(shù)全切患者術(shù)后治愈率比未全切患者要高;催乳素微腺瘤患者比大腺瘤患者術(shù)后治愈率要高;術(shù)后第1天PRL20ng/ml比PRL20ng/ml患者復(fù)發(fā)率要低,術(shù)后第1天PRL水平可作為預(yù)測(cè)復(fù)發(fā)的指標(biāo)之一;侵襲性PRL腺瘤比非侵襲性PRL腺瘤患者復(fù)發(fā)率高,侵襲性PRL腺瘤術(shù)后需行綜合治療。
[Abstract]:Objective: to evaluate the effect of transsphenoidal resection of pituitary PRL adenoma. Methods: the clinical data of 35 patients undergoing transsphenoidal pituitary PRL adenectomy in our hospital were retrospectively analyzed. The serum PRL levels were measured before and after operation, and the factors that might affect the outcome of the operation were analyzed statistically, such as tumor size, tumor resection degree and invasion. Results: the incidence rate of males was lower than that of females. The most common clinical manifestations caused by the space-occupying effect were headache 34.29 and visual disturbance 400.Endocrine abnormality led to the decrease of sexual function in male patients (18.75), and the main manifestations of women were amenorrhea (73.68), lactation (21.05%), infertility (26.32 2). There were significant differences in preoperative PRL levels (P < 0.047); difference in tumor size between male and female patients (P < 0.009); influence of preoperative PRL level on PRL level on the first day after operation (P < 0.033); the cure rate of total tumor resection patients was higher than that of non-total resection patients (P < 0.006); The recurrence rate of PRL20ng/ml was different from that of PRL 20ng / ml on the first day after operation, and the recurrence rate of invasive and non-invasive PRL adenoma was significantly different from that of non-invasive PRL adenoma. Conclusion: the PRL level of male patients was higher than that of PRL200ng/ml patients, the cure rate of PRL200ng/ml patients before operation was lower than that of PRL200ng/ml patients before operation, the cure rate of patients with total operation was higher than that of patients without total resection. The postoperative cure rate of prolactin microadenoma patients was higher than that of macroadenoma patients, the recurrence rate of PRL20ng/ml was lower than that of PRL20ng/ml patients on the first day after operation, and the level of PRL on the first day after operation could be used as a predictor of recurrence. The recurrence rate of invasive PRL adenoma is higher than that of non-invasive PRL adenoma. The invasive PRL adenoma needs comprehensive treatment after operation.
【學(xué)位授予單位】：廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R736.4

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;女性高催乳素血癥診治共識(shí)[J];中華婦產(chǎn)科雜志;2016年03期

2 施燾;幸兵;;妊娠期催乳素腺瘤的診治進(jìn)展[J];中華神經(jīng)外科雜志;2015年10期

3 劉陽(yáng);時(shí)璇;王任直;;不同性別垂體催乳素腺瘤患者臨床差異與雌激素受體表達(dá)的關(guān)系[J];中華神經(jīng)外科雜志;2015年08期

4 ;中國(guó)垂體腺瘤外科治療專家共識(shí)[J];中華醫(yī)學(xué)雜志;2015年05期

5 吳哲褒;;應(yīng)重視垂體催乳素腺瘤的藥物治療[J];中華醫(yī)學(xué)雜志;2014年31期

6 郁琦;;多科協(xié)作提高垂體催乳素腺瘤的診治水平[J];中華醫(yī)學(xué)雜志;2014年31期

7 位振清;王任直;姚勇;鄧侃;王劍新;劉小海;代從新;;多技術(shù)輔助神經(jīng)內(nèi)鏡下侵襲海綿竇的垂體腺瘤的治療[J];中國(guó)醫(yī)學(xué)科學(xué)院學(xué)報(bào);2014年02期

8 馬杰科;幸兵;王任直;連偉;姚勇;鄧侃;;表現(xiàn)為動(dòng)眼神經(jīng)麻痹的垂體腺瘤卒中的診治(附15例分析)[J];中華神經(jīng)外科疾病研究雜志;2014年02期

9 位振清;王任直;姚勇;鄧侃;王劍新;劉小海;代從新;;侵襲性垂體腺瘤的診斷和治療[J];大連醫(yī)科大學(xué)學(xué)報(bào);2014年01期

10 甄甄;雷琢瑋;雷霆;;垂體泌乳素微腺瘤治療進(jìn)展[J];中國(guó)臨床神經(jīng)外科雜志;2014年01期

，

本文編號(hào)：1800201